Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-14-003160
Filing Date
2014-11-17
Accepted
2014-11-17 17:28:11
Documents
9
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q avtherapeutics10q093014.htm 10-Q 481778
2 EX-31.1 ex31-1.htm EX-31.1 16788
3 EX-32.1 ex32-1.htm EX-32.2 6266
  Complete submission text file 0001185185-14-003160.txt   3727780

Data Files

Seq Description Document Type Size
4 EX-101.INS avth-20140930.xml EX-101.INS 547851
5 EX-101.SCH avth-20140930.xsd EX-101.SCH 32843
6 EX-101.CAL avth-20140930_cal.xml EX-101.CAL 20622
7 EX-101.DEF avth-20140930_def.xml EX-101.DEF 161111
8 EX-101.LAB avth-20140930_lab.xml EX-101.LAB 223573
9 EX-101.PRE avth-20140930_pre.xml EX-101.PRE 161745
Mailing Address 20 EAST 68TH STREET, SUITE 204 NEW YORK NY 10065
Business Address 20 EAST 68TH STREET, SUITE 204 NEW YORK NY 10065 917-497-5523
AV Therapeutics, Inc. (Filer) CIK: 0001537293 (see all company filings)

EIN.: 331222799 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55149 | Film No.: 141228863
SIC: 2040 Grain Mill Products